
Cellectis
Allogeneic, Gene editing, Genome Engineering, Life sciences, off-the-shef CART therapies, Oncology, T-Cell therapies
Cellectis was incorporated in 1999 and is located in Paris, France. The company specialises in Allogeneic, Gene editing, Genome Engineering, Life sciences, off-the-shef CART therapies, Oncology, T-Cell therapies with an estimated revenue and employee in the range of $10 to $50 million and 51-200 respectively.
We have 151 contacts in our database, out of which 32% are decision makers. The distribution of leads are as follows:
In September, 2019 cellectis.com's total website visitor was 14086, declined by 37% from previous month. Some key metrics are Average time spent on site is 6 minutes, Bounce Rate is 65% and average page per visit is 3 respectively.
We Verified cellectis.com server for email deliverability.
Adobe is a global name in software industry. But software industry has too many participants that...
T-Mobile reached a definitive agreement to acquire the Sprint-branded wireless operating assets o...
Being an American multinational company Cognizant has access to a huge section of the IT industry...
SVB Financial Group to acquire Boston Private, a leading provider of wealth management, trust and...
Amazon.com is a worldwide name in the Internet and E-Commerce industry. Amazon may be termed as t...